Currently, Glenn Gundersen occupies the position of Medical Director for SoftOx Solutions AS.

He previously was Director-Pharmaceutical Development at ArcticZymes Technologies ASA, Head-Business Unit Oncology Drug Portfolio at Bristol-Myers Squibb Norway Ltd. and Head-Medical at Biogen Norway AS.

Dr. Gundersen received a doctorate from the University of Oslo.